Frazier Life Sciences Management’s Design Therapeutics DSGN Stock Holding History

Frazier Life Sciences Management’s Portfolio DSGN Stock Details DSGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-521,000	Closed	-$4.89M	–	40
2025 Q4	$4.89M	Sell	521,000 -1,432,547	-73%	-$11.2M	0.13%	38
2025 Q3	$14.7M	Hold	1,953,547	–	–	0.44%	34
2025 Q2	$6.58M	Hold	1,953,547	–	–	0.26%	42
2025 Q1	$7.54M	Hold	1,953,547	–	–	0.34%	35
2024 Q4	$12.1M	Buy	1,953,547 +61,000	+3%	+$353K	0.5%	33
2024 Q3	$10.2M	Buy	1,892,547 +697,368	+58%	+$3.28M	0.41%	37
2024 Q2	$4M	Buy	+1,195,179	New	+$4.66M	0.19%	46

Other funds holding DSGN

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Logos Global Management San Francisco, California $1.94B AUM 444.09% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM